Third-quarter revenue amounts to CHF 551 million, an increase of 12%, bringing revenue in the first nine months of 2022 to CHF 1.7 billion All regions performing well with LATAM leading organic growth with 21% Roxolid SLActive study highlights preclinical premium implant outcome ClearCorrect received regulatory approval in China Investment in SmileCloud, a smile design […]
continue readingStraumann Group reports very strong first quarter
. Quarterly revenue of CHF 589 million, 27.2% organic revenue growth on previous year Strong organic double-digit growth in all regions; LATAM fastest-growing Launch of two innovative challenger brand implants, Neodent Zi and Anthogyr X3 Acquisition of a strategic minority stake in CareStack, a cloud-based practice management software Outlook for 2022 confirmed: Organic revenue growth […]
continue readingStraumann Group announces new Executive Management Board members to support growth strategy
Jason Forbes joins as Straumann Group Chief Consumer Officer, a newly created position in the Executive Management Board Sébastien Roche appointed as Chief Operations and Supply Chain Officer Changes are designed to achieve ambitious growth in line with the company’s emphasis on digital transformation and aspiration to build a consumer presence New leadership roles […]
continue readingStraumann Group presents evolved strategy to achieve its long-term revenue ambition of CHF 5 billion
Ambition to achieve CHF 5 billion revenue by 2030 considering an average organic growth rate of at least 10%, core EBIT margin expected to range between 25-30% in the next years depending on investment, and on continuous increase of gross dividend Culture remains a key pillar with an employee engagement score of 80 in […]
continue readingStraumann Group Capital Markets Day 2021
Straumann Group invites you to attend our Capital Markets Day 2021 on Thursday, December 16, 2021. Due to the uncertainty and travel restrictions related to the COVID-19 pandemic, it will be held in a virtual format only. The Group is evolving from an implant to an oral care company. At the Capital Markets Day, we will provide more […]
continue readingStraumann Group further accelerates growth in the second quarter to deliver record first half-year result
Half-year revenue reached CHF 986 million or 63% organic growth Revenue increased by 103% to reach CHF 516 million in the second quarter, with all regions reporting impressive sales growth Strong volume growth brought core EBIT to CHF 284 million, with a margin of 29% Reported net profit rose to CHF 175 million or 18%, […]
continue reading